Henderson Jane (CIK 1422304) reported 27 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-24). Recent activity: Sell APGE (15,000 shares), Sell APGE (811 shares), Sell APGE (900 shares), Sell APGE (289 shares), Sell APGE (2,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-24 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 15,000 | $0 |
| 2026-05-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 811 | $65,707 |
| 2026-05-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 900 | $74,340 |
| 2026-05-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 289 | $24,033 |
| 2026-04-17 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 2,000 | $180,000 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 900 | $76,014 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 1,100 | $94,006 |
| 2026-03-27 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 2,000 | $170,000 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 300 | $20,481 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 300 | $20,829 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 994 | $70,027 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 406 | $29,094 |
| 2026-02-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 792 | $51,646 |
| 2026-02-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 1,108 | $73,294 |
| 2026-02-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 100 | $6,689 |
| 2026-01-06 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 1,920 | $142,330 |
| 2026-01-06 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 4,080 | $306,816 |
| 2026-01-06 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 2,000 | $160,000 |
| 2025-12-23 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 1,500 | $120,000 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 9,398 | $0 |
| 2025-12-05 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 1,500 | $112,500 |
| 2025-11-28 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 1,500 | $105,000 |
| 2025-11-14 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 2,000 | $130,000 |
| 2025-11-13 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | Sell | 1,000 | $60,000 |
| 2025-08-12 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 3,000 | $21,030 |
Source: SEC Form 4 filings · as of 2026-07-24